K(+) channel blockers and cytochrome P450 inhibitors on acetylcholine-induced, endothelium-dependent relaxation in rabbit mesenteric artery

Eur J Pharmacol. 1999 Nov 12;384(1):7-15. doi: 10.1016/s0014-2999(99)00663-9.

Abstract

Acetylcholine caused an endothelium-dependent relaxation in isolated rabbit mesenteric small artery in the presence of nitro L-arginine and indomethacin. The acetylcholine-induced relaxation was attenuated by high K(+) solution, suggesting that the response is mediated by a membrane potential-sensitive mechanism, presumably an endothelium-derived hyperpolarizing factor. The acetylcholine-induced relaxation was also inhibited with tetraethylammonium, 4-aminopyridine and charybdotoxin, but not with Ba(2+), apamin, iberiotoxin nor glibenclamide. The relaxation was abolished by a combination of apamin and charybdotoxin, but iberiotoxin could not replace charybdotoxin in this combination. The responses to charybdotoxin and 4-aminopyridine were synergistic but neither apamin nor iberiotoxin increased the effect of 4-aminopyridine. Clotrimazole and proadifen inhibited the acetylcholine-induced relaxation, but these drugs also inhibited the cromakalim-induced relaxation, while protoporphyrin IX inhibited the acetylcholine- but not cromakalim-induced relaxation. 17-Octadecynoic acid and 1-aminobenzotriazole did not affect the response to acetylcholine. Four regioisomers of epoxyeicosatrienoic acids did not relax endothelium-denuded artery. A gap junction inhibitor 18alpha-glycyrrhetinic acid attenuated the relaxation to acetylcholine. It is suggested that in rabbit mesenteric artery, the acetylcholine-induced, nitric oxide- and prostacyclin-independent relaxation is mainly mediated by 4-aminopyridine- and charybdotoxin-sensitive K(+) channels and that the relaxation is not mediated through cytochrome P450 enzyme metabolites. The contribution of heterocellular gap junctional communication to the relaxation is discussed.

MeSH terms

  • 8,11,14-Eicosatrienoic Acid / analogs & derivatives
  • 8,11,14-Eicosatrienoic Acid / pharmacology
  • Acetylcholine / pharmacology*
  • Animals
  • Arachidonic Acids / pharmacology
  • Cromakalim / pharmacology
  • Cytochrome P-450 Enzyme Inhibitors*
  • Dose-Response Relationship, Drug
  • Endothelium, Vascular / physiology*
  • Enzyme Inhibitors / pharmacology
  • Glycyrrhetinic Acid / pharmacology
  • Male
  • Mesenteric Arteries / drug effects*
  • Mesenteric Arteries / physiology
  • Muscle Relaxation / drug effects*
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / physiology
  • Nitroprusside / pharmacology
  • Norepinephrine / pharmacology
  • Potassium Channel Blockers*
  • Potassium Chloride / pharmacology
  • Rabbits
  • Tetraethylammonium / pharmacology
  • Vasoconstrictor Agents / pharmacology
  • Vasodilator Agents / pharmacology

Substances

  • Arachidonic Acids
  • Cytochrome P-450 Enzyme Inhibitors
  • Enzyme Inhibitors
  • Potassium Channel Blockers
  • Vasoconstrictor Agents
  • Vasodilator Agents
  • arachidonyltrifluoromethane
  • Cromakalim
  • Nitroprusside
  • Tetraethylammonium
  • Potassium Chloride
  • 8,11,14-Eicosatrienoic Acid
  • Acetylcholine
  • Glycyrrhetinic Acid
  • Norepinephrine